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Protein–proteinGap junctional channels are a class of membrane channels composed of transmembrane channel-forming in-
tegral membrane proteins termed connexins, innexins or pannexins that mediate direct cell-to-cell or cell-to
extracellular medium communication in almost all animal tissues. The activity of these channels is tightly
regulated, particularly by intramolecular modiﬁcations as phosphorylations of proteins and via the formation
of multiprotein complexes where pore-forming subunits bind to auxiliary channel subunits and associate
with scaffolding proteins that play essential roles in channel localization and activity. Scaffolding proteins
link signaling enzymes, substrates, and potential effectors (such as channels) into multiprotein signaling
complexes that may be anchored to the cytoskeleton. Protein–protein interactions play essential roles in
channel localization and activity and, besides their cell-to-cell channel-forming functions, gap junctional pro-
teins now appear involved in different cellular functions (e.g. transcriptional and cytoskeletal regulations).
The present review summarizes the recent progress regarding the proteins capable of interacting with junc-
tional proteins and highlights the function of these protein–protein interactions in cell physiology and aber-
rant function in diseases. This article is part of a Special Issue entitled: The Communicating junctions,
composition, structure and functions.
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Intercellular communication is of paramount importance in allow-
ing individual cells to successfully act in a co-ordinated manner in
multicellular organisms and tissues. Gap junctional intercellular com-
munication (GJIC) relies on intercellular protein channels which span
the lipid bilayers of contiguous cells, allowing them to directly ex-
change ions and small molecules. All junctional channels have a simi-
lar overall structure but, unlike many other membrane channels,
different gene families encode the membrane proteins that form
them in different animal phyla. The intercellular junctional channel
is made by end-to-end docking of two hemichannels, each of which
is an oligomer of transmembrane protein subunits, termed innexins
(Inxs) in invertebrates, and connexins (Cxs) and pannexins (Panxs)
in chordates (see [1]), forming an aqueous pore in the lipid bilayer. If
pannexins were found able to form cell-to-cell channels in paired oo-
cytes [2], an uncertainty remains on this capability in native tissues.
Intercellular dye or electrical couplings are indeed generally absent
in a variety of pannexin-expressing host cells (see [3]) but a Ca2+
wave propagation between osteoblasts was recently ascribed to
Panx3 gap junctions [4].
Cxs, Inxs and Panxs have a common topology, with four alpha-
helical transmembrane domains, two extracellular loops, a cytoplas-
mic loop, and N- and C-termini located on the cytoplasmic membrane
face. Historically, the unpaired hemichannels scattered in nonjunc-
tional membranes were considered as remaining permanently closed
to avoid cell death, but several data reported in the past decade
revealed that at least some of them mediated paracrine signaling by
providing a ﬂux pathway for ions such as Ca2+, for ATP, glutamate
and plausibly for other compounds, in response to physiological and
pathological stimuli.
The properties of single membrane channels and intercellular
channels are, as those of other membrane channels, determined by
their 3-dimensional structure and related interactions with regulato-
ry proteins. Structures that include channel-subunits and regulatoryproteins depend on the microdomains that incorporate protein con-
stituents. Multiprotein complexes associate pore-forming structures
with scaffolding proteins that link signaling enzymes, substrates,
and potential effectors (including channels) into a signaling complex
anchored to the cytoskeleton. Besides an obvious role in targeting the
channel to a particular location on the cell membrane, there are sev-
eral advantages to having a membrane channel in a multiprotein
complex. Indeed, the substrate selectivity of some enzymes, essential
to determining speciﬁcity in several signal transduction pathways, is
largely determined by their subcellular location (e.g. for protein ki-
nases and phosphatases). There is also a large increase in the efﬁcien-
cy of the reaction kinetics when an enzyme is localized with its
substrate and effector in a microenvironment with restricted diffu-
sion. Moreover, the anchoring of enzyme complexes to some chan-
nels may be necessary for the extremely rapid transmission of
signals required to regulate the activity of these channels. However,
if the proteins in signaling cascades are considered spatiotemporarily
organized in such a way to achieve efﬁciency and speciﬁcity, the
physical association of components to form signaling complexes or
their close proximity to facilitate random collisions still remains poor-
ly understood and largely focused on Cx43, owing in large part to its
ubiquitous distribution in mammalian tissues.
Many signaling pathways and regulatory systems in eukaryotic
cells are controlled by proteins with multiple interaction domains
that mediate speciﬁc protein–protein and protein–phospholipid in-
teractions. Pairs of interacting partners at protein–protein (or pro-
tein–peptide) interfaces interact via modular protein domains that
are well demarcated and independently folded domains, typically
comprising 40 to 200 amino acids. These domains are non-catalytic
and bind speciﬁcally to short continuous peptide sequences in their
binding partner(s) via one or more exposed, ligand-binding surfaces
(“ligand recognition pockets”). Ligands interact with their comple-
mentary domains through short and generally continuous sequence
motifs. In some cases, certain amino acids of the ligands must be
post-translationally modiﬁed (phosphorylated, acetylated, methylated,
1846 J.-C. Hervé et al. / Biochimica et Biophysica Acta 1818 (2012) 1844–1865etc.) before recognition and binding can occur (see for example [5]).
The protein–protein interactions may act in concert as “molecular
switches”, changing the properties of the channels (or their ability to
be regulated by other factors) in response to modiﬁcations in the
channel microenvironment.
2. Intramolecular interactions between gap junction proteins
The assembly of gap junction molecules into a connexon, an
innexon or a pannexon, made of single (homomeric) or multiple
(heteromeric) protein isotypes is based on speciﬁc signals located
within the polypeptides. Cxs, Inx and Panx1 assemble into hexamers
and Panx2 into octamers (the oligomeric number of a Panx3 mem-
brane channel has not yet been determined; see [6]). These proteins
have conserved cysteine residues in their extracellular loops (six in
Cxs (except Cx23; [7]), four in Inxs, Panx1 and Cx23) that form
intra-protein disulﬁde bonds (for review, see for example [8]). The
head-to-head binding between two connexons or two innexons oc-
curs via non-covalent interactions between the extracellular loops
of apposing hemichannels. Pannexins, in contrast with both Inxs
and Cxs, contain glycosylation sites in their extracellular loops [9].
Presumably, such glycosylation not only plays a role in trafﬁcking of
Panx1 to the membrane, but also poses a steric barrier to formation
of pannexon linkage across the extracellular space (see above).
Thus, the role of pannexin channels is most likely to involve exchange
from extracellular space, rather than between cells, directly or
through associations with several P2 purinergic receptors (see
Section 3.5).
Mutagenesis studies suggest that the docking region contains beta
structures, and may resemble to some degree the beta-barrel struc-
ture of porin channels. The hemichannels that compose one intercel-
lular channel are rotationally staggered by ~30° relative to each other
so that the alpha helices of each connexin monomer are axially
aligned with the alpha helices of two adjacent monomers in the ap-
posed hemichannel (for review, see [10]). The second extracellular
(E2) domain [11] together with the middle cytoplasmic portion [12]
determine the heterotypic compatibility between connexins. The
docking process of connexons could be hindered by competition
with oligopeptides homologous to speciﬁc regions of the extracellular
loops of connexins (for recent review, see [13]).
Formation of heterotypic channels, i.e. docking of two hemichan-
nels composed of different connexin isotypes was at ﬁrstTable 1
Reported interactions between gap junction proteins in preparations which endogenously
Protein Via its And Motif Main approachesa









Cx32 Cx47 gt cl
Cx33 Cx43 cl ci
Cx40 Cx43 ci ep
at bt nmr
ep
Cx43, possibly Cx37 ep
Cx43, Cx45 cl ep
Cx46 Cx50 ci
Inx2 C-terminal Inx3 C-terminal cl ci dh at
Inx2 C-terminal Inx3 C-terminal at
a : bt: biochemical techniques (cell-free assays, chimeras, truncated connexins, mimetic p
ﬁnity techniques (pull-down, afﬁnity binding assays, surface plasmon resonance); em: elec
diffusion.controversial but several associations have now been observed in
situ (see Table 1). In A7r5 cells for example, He et al. [14] reported
that Cx40 and Cx43 failed to form functional heterotypic channels
but built heteromeric channels with unique functional properties
(conductances, gating behaviors or selectivities) relative to the
homomeric forms.
Connexin intramolecular interactions have been suggested to be
responsible for the interruption of the cell-to-cell communication
elicited by different stimuli (including pH, insulin, and the fast
component of voltage-dependent gating for example), via interac-
tions between the channel pore and a discrete C-terminal domain
of the connexin serving as gating particle, a “ball and chain”,
model [15–22] analogous to the inactivation of Shaker-type K+
channels [23].
Several lines of evidence indeed imply that the CT domain of Cxs
and Inxs is a movable structure, able to behave like an independent
domain. Indeed, truncation of this domain in Cx40 or Cx43 resulted
in alterations in their single channel activity. However, normal func-
tions were restored by co-expression of the CT domain, even of anoth-
er connexin. Thus, C-tails of other connexin family members can
functionally substitute, for example Cx40 truncated at amino acid
248 (Cx40tr248) function is – partially – restored by separate co-
expression of the heterologous Cx43-CT fragment [21,24,25]. Both
Cx40CT and Cx43CT were reported to be intrinsically disordered pro-
teins, being able to interact with each other; the CT domains of Cx40
and Cx43 can indeed interact with the CL domains of Cx40 and Cx43
(and vice versa, respectively; [26]).
These hetero-domain interactions (occurring between the CT do-
main of one connexin isotype and the pore-forming region of anoth-
er) suggest that, despite their differences in primary sequence, the CT
domains of Cx40 and of Cx43 can reach a similar conformation, allow-
ing their interaction with a common binding domain. Such intramo-
lecular interaction, by analogy with other biological reactions
involving two separate molecules (e.g. ligand and receptor), is viewed
as an intramolecular noncovalent interaction of the CT domain (act-
ing as a ligand) with a domain in or near the mouth of conductive
path (acting as a receptor). The second half of the cytoplasmic loop
of Cx43 (amino acids 119 to 144) able to bind to the CT domain of
the same protein, has been proposed to act as the receptor for the gat-
ing particle [22,27,28]. Consequently, mimetic peptides were able to
prevent the gating of channels. Peptides containing the sequence
“RXP” as a consensus Cx43CT binding motif prevented heptanol –express them.
Cells or tissues References
Mouse cochlea [247]
Mouse cochlea [248]
Guinea pig liver [249]
Mouse hepatocytes [250]
Mouse mammary gland [251]
Rat liver [252]
Mouse astrocyte–oligodendrocyte junctions [246]
Rodent hepatocytes [253]
Rat Sertoli cells [224]
Mouse oligodendrocytes [246]
Rat Sertoli cells [177]
A7r5 cells [14]
[26]
Human mesenchymal stem cells, canine ventricular myocytes [254]
Rat basilar artery smooth muscle [255]




eptides, etc.); cl: colocalization; ci: co-immunoprecipitation; dh: double hybrid; at: af-
tron microscopy immuno labeling; ep: electrophysiology; gt: gene targeting; td: tracer
Box 1
Protein modules and Cx43 signaling.
Many genes that have different functions and lack significant
overall homology at the nucleic acid sequence level, encode
proteins with structurally similar domains. The X-ray diffrac-
tion/crystallography technique revealed that the homology in
primary sequence is even more pronounced in the three-
dimensional structure. Because of their predictive value in sig-
nal transduction, the domains directly involved in Cx43 gap
junctions are briefly introduced. For more details on protein–
protein interaction domains involved in signal transduction,
the reader is referred to Pawson and Scott [35] and Sudol
[37]. The conformation of the proteins participating in pro-
tein–protein interactions is crucial. One way to alter these con-
formations is by (de-)phosphorylation.
PSD95/Disk large/ZO-1 homology domain (PDZ)
PDZ (80–90 amino acids) domains have a hydrophobic pocket
that binds the very C-terminal residues of their target proteins
[38]. Target proteins include multi-spanning transmembrane
proteins such as receptors and ion channels. Two classes of
PDZ-binding consensus sequences have now been identified:
Class 1: -x-S/T-x-V/I/L-COOH; Class 2: -x-V/I/L-x-V/I/L-COOH
[36]. Recent evidence shows that binding to internal hydropho-
bic sequences can occur, and that PDZ domains can form het-
erodomain interactions [39]. One of the best described
examples of clustering signal and effector proteins via PDZ do-
mains is InaD, which forms a peripheral membrane signaling
complex at rhodopsin receptors (see [40] for details).
Src Homology 2 domain (SH2)
SH2 domains characteristically bind phospho-tyrosine residues
in a hydrophobic pocket. An additional pocket confers sub-
strate specificity by binding amino acids more C-terminally lo-
cated. Upon tyrosine phosphorylation of the substrate, SH2
modules associate with their substrates. One well-
documented example of specific SH2-tyrosine binding is the
activated PDGF receptor [41].
Src Homology 3 domain (SH3)
The other well-known Src-homology domain, the SH3 domain,
binds proline-rich sequences. Aliphatic prolines residues of the
substrate located on one side of an alpha-helix bind separately
to hydrophobic pockets in the SH3 domain. As for the other
protein domains, the flanking amino acids of the consensus se-
quence determine binding specificity. For example, the v-Src
SH3 domain has been shown to bind to a specific proline-rich
stretch in Cx43 [42].
For a comprehensive overview of other domains implicated in
connexin interactions, see [43].
1847J.-C. Hervé et al. / Biochimica et Biophysica Acta 1818 (2012) 1844–1865and low pH – induced uncoupling junction closure, and action poten-
tial propagation block [28,29], and peptides corresponding to either
the last 10 CT aa of Cx43 or to the L2 region (aa 119–144 in the CL)
altered the activity of Cx43 hemichannels [30], for example.
The dimerization of the Cx43CT was suggested to be one of the
structural changes involved in the pH regulation of Cx43, increas-
ing the Cx43CT/Cx43CL binding afﬁnity to bring the channel to a
closed state [31,32], being important for heteromeric channel
regulation.
The binding of Inx2 and Inx3 via their CT was proposed to provide
a mechanism for oligomerization of heteromeric channels [33]. An in-
teraction between Panx1 and Panx2, initiated while these pannexins
are still residents of the endoplasmic reticulum and consistent with
the potential formation of mixed Panx1/2 channels, was observed in
NRK and HEK 293 cells [34]. In this study, in contrast, Panx1/Panx3
physical interaction only occurred when Panx1 was not glycosylated
or glycosylated to only the Gly1 species.
3. The protein partners of gap junctional proteins
Proteins are endowed with a capability of steric ﬁtting with
other proteins to form high molecular weight complexes with emer-
gent functions. Protein–protein interactions often take place via spe-
cial domains of the peptide chains [35] (see Box 1 for more details);
among them, PDZ (Postsynaptic density-95/Disk large/Zonula
occludens-1) motifs are of special interest since they often are
found to bind C-terminal hydrophobic amino acids of transmem-
brane proteins. PDZ domains are 80–100-amino acid protein binding
cassettes, identiﬁed initially in PSD-95, Dlg, and ZO-1, that can rec-
ognize the very C-terminal amino acid residues of their binding
partners [36], but also have been implicated in homodimerization,
heterodimerization and binding other regions of proteins (see
below).
PDZ proteins are classiﬁed according to their modular organiza-
tion (for review, see [44]). Proteins in the MAGUK (membrane-asso-
ciated guanylate kinase) family are characterized by multiple PDZ
domains, one SH3 domain, and one GUK-like domain (for review
see [45]). The Src homology 3 (SH3) domains can interact with
proline-rich motifs whereas Src homology 2 (SH2) domains associate
with phosphotyrosine-containing sequences. The GUK-like domain
may also allow for multiprotein interactions [46]. MAGUK proteins
have emerged as key elements in the organization of protein com-
plexes in specialized membrane regions (e.g. synapses or intercellular
junctions). Via their multiple protein–protein interaction domains,
they interact with a wide range of membrane receptors and ionic
channels. Several proteins have been reported to be able to interact
(Table 2) or only to co-localize (not quoted) with different GJ
proteins.
3.1. Cytoskeletal proteins
In contrast with tight junctions and adherens junctions, known for
a long time to interact with the actin cytoskeleton, gap junctions were
only recently reported to associate, frequently via adaptors, with the
actin cytoskeleton. Actin has been reported to directly interact with
Panx1 (preferentially F-actin; [47]) and with Cx30 [48], in contrast
with other connexins, Cx43 for example, of which binding to actin is
thought to occur indirectly. Using a combination of atomic force mi-
croscopy and immunocytochemistry, Yamane et al. [49] suggested
an association between Cx43 and the tip of actin ﬁlaments in embry-
onic rat astrocytes. Among the F-actin-binding proteins which con-
nect extra- and intracellular stimuli to cytoskeleton modeling and
reorganization, Drebrin (“Developmentally regulated brain protein”),
was identiﬁed as a binding partner of the C-tail Cx43 in mouse brain
homogenates [50] and cortactin co-immunoprecipitated and co-
localized with Cx43 and F-actin in C2C12 cells [51]. Cx43 wasshown to bind to microtubules [52]; α-tubulin and β-tubulin
appeared equally bound [53].
3.2. Scaffold proteins (Zonula Occludens proteins)
In the different junctional complexes, adaptor proteins, which
possess a modular organization with several protein–protein interac-
tion domains, usually bind to the cytoplasmic C-terminal tail of trans-
membrane proteins and connect them to the actin cytoskeleton
directly or indirectly by recruiting other proteins, creating and main-
taining multiprotein complexes. Zonula Occludens (ZO) proteins, in
Table 2
Reported interactions of junctional proteins with membrane-associated proteins.
Partner protein Via its Cx Cx motif Main approachesa Cell typesb References
Calmodulin Cx32 NT (aa 1–21); CT (aa 216–230) bt [93]
M3, C-terminal bt ci COS-7 cells [152]
Cx35/Cx36/Cx34.7 First residues (10 to 30) of the CT at [258]
Cx43 Cytoplasmic loop (aa 136–158) at nmr [143]
Cx44 Cytoplasmic loop (aa 129–150) bt nmr [143]
Cx50 Cytoplasmic loop and C-terminal cl ci HeLa cells [94]
Cytoplasmic loop (aa 141–166) bt nmr [142]
ZO-1 PDZ-2 Cx30 cl ci at Mouse brain and spinal cord [259]
PDZ-2 Cx31.9 The most C-terminal residues cl ci HEK 293 cells [130]
Cx32 cl ci Cultured rat hepatocytes [68]
PDZ-1 Cx36 Four C-terminal residues (SAYV) cl ci em at Mouse brain, HeLa cells [136]
PDZ-1 A 14-residue C-terminal fragment cl ci at HeLa cells, β TC-3, mouse pancreas and
adrenal gland cells
[135]
cl ci P C12 cells [260]
PDZ-1 cl ci Mouse retina, HeLa cells [163]
PDZ-1 Cx35 (orth. hCx36) Four C-terminal residues (SAYV) cl ci at Goldﬁsh brain sect ions, HeLa cells [244]
C40 cl ci Porcine vascular endothelial cells [71]
PDZs Cx43 C-terminal 5 residues cl ci at HEK 293 cells, rat cardiomyocytes [59]
PDZ-2 Extreme C-terminal cl ci dh COS-7, Rat -1, mink lung epithelial cells [60]
PDZ-2 C-terminal 5 residues cl ci em Rat adult ventricular myocytes [194]
cl ci 42GP A9 cells, rat test is lysates [261]
PDZ-2 C-terminal ci at C57B16 mouse cortical astrocytes [101]
PDZ-2 Last 19 C-terminal residues nmr [129]
PDZ-2 CTl (residues at the -3 position) cl ci dh MDCK cells [128]
PDZ-2 cl ci at Mouse brain and spinal cord [259]
PDZ-2 C-terminal (amino acids) cl at HeLa cells, rat cardiomyocytes [62]
cl ci Porcine vascular endothelial cells [71]
PDZ-2 C-terminus cl ci NRK and HEK 293 cells [262]
cl ci at Human trophoblastic cells [216]
cl ci HeLa cells [162]
Cx43, Cx45 cl ci at ROS 17/2.8 cells [140]
PDZs Cx45 C-terminal 4 residues cl ci dh MDCK cells [131]
12 most C-terminal residues cl ci at ROS 17/2.8 cells [189,263]
PDZ-2 cl ci at em HeLa cells [163]
PDZ-2 Cx46, Cx50 Most C-terminal residues cl ci Mouse lens [132]
PDZ-2 Most C-terminal residues cl ci em at Mouse lens [134]
PDZ-2 Cx47 cl ci em at Mouse brain, HeLa cells [133]
ZO-2 Cx43 C-terminal end at NRK cells [264]
PDZ-2 C-terminal end cl ci dh NRK, HEK 293T cells, heart tissues [64]
PDZ-1 Cx36 Four C-terminal residues (SAYV) cl ci at HeLa and β TC-3 cells [223]
ZO-3 PDZs Cx45 C-terminal 4 residues cl ci dh MDCK cells [131]
PDZ-1 Cx36 Four C-terminal residues (SAYV) cl ci at HeLa and β TC-3 cells [223]
Occludin Cx26 at Human intestinal cell line T 84 [69]
Cx40, Cx43 cl ci Porcine vascular endothelial cells [71]
Cx32 cl ci CHST8 cells [67]
cl ci Cultured rat hepatocytes [68]
Claudin-1 Cx32 cl ci Cultured rat hepatocytes [68]
Claudin-5 Cx40, Cx43 cl ci Porcine vascular endothelial cells [71]
MUPP-1 PDZ Cx47 C-terminus cl ci Mouse brain and sciatic nerve [72]
β-catenin Cx43 cl ci Neonatal rat cardiomyocyte, N2A cells [77]
ci Rat Sertoli cells [205]
p120 Cx43 cl ci NIH 3T3 cells [75]
N-Cadherin Cx43 cl ci NIH 3T3 cells [75]
ci Rat Sertoli cells [205]
Plakophilin-2 Cx43 ci Rat Sertoli cells [205]
Ankyrin-G Cx43 ci Rat adult heart lysates [181]
Integrin α5/β 1 Cx43 cl ci NIH 3T3 cells [265]
Crumps Inx2 cl ci dh at Drosophila embryos [80]
AQP0 C-ter Cx45.6, Cx56 cl ci at Embryonic chick lens [266]
C-ter Cx45.6 Cytoplasmic loop ci at Embryonic chick lens [82]
C-ter Cx50 Cytoplasmic loop cl at Chick lens [83]
Nav 1.5 Cx43 cl ci Mouse myocardium [81]
mAChR Cx43 cl ci Rat myocardium [84]
P2X7 Cx43 cl at Mouse macrophages, J774 cells [87]
Panx1 ci HEK 293 cells [88]
a : bt: biochemical techniques (cell-free assays, chimeras, truncated connexins, mimetic peptides, oligomerization assays, chemical cross-linking tests, …etc.); cl: colocalization;
ci: co-immunoprecipitation; fs: co-fractionation or co-sedimentation; dh: double hybrid; em: electron microscopy immuno labeling; at: afﬁnity techniques (pull-down, afﬁnity
binding assays, surface plasmon resonance); nmr: nuclear magnetic resonance.
b : in roman characters, cells where Cxs were endogenously expressed; in italics, cells where Cxs were exogenously expressed, surexpressed or mutated.
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(PDZ, SH3 and GUK domains), have a distinctive C-terminus compris-
ing acidic- and proline-rich regions. ZO-1, a 220 kDa peripheral mem-
brane protein, tethers transmembrane proteins either directly (e.g.connexins, occludin, claudins, tricellulin, CAR (coxsackievirus and ad-
enovirus receptor) and JAMs) or via their adapter proteins, e.g. α-
catenin or afadin, to the actin cytoskeleton [54–57]. All Cxs explored
so far have been found to be able to associate with ZO proteins
1849J.-C. Hervé et al. / Biochimica et Biophysica Acta 1818 (2012) 1844–1865(Table 2), thus ZO proteins may play a general role in the formation,
distribution and turnover of gap junctions and/or in recruiting signal-
ing molecules that regulate intercellular communication. Moreover,
ZO proteins also exhibit several nuclear localization (NLS) and nucle-
ar export signals (NES), which may enable them to shuttle between
the cytoplasm and the nucleus (for recent review, see for example
[58]), to transduce signals leading to altered gene expression and
cell behavior.
Cx43 was the ﬁrst connexin found to interact with a ZO protein
[59,60], and this interaction has been subsequently observed in a va-
riety of cell types (Table 2). Cx43-ZO-1 associations do not necessarily
overlap directly with whole junctional plaques, and ZO-1 has fre-
quently been observed only at the plaque perimeter [61–63]. The
ﬁnding that the C-terminus of Cx43 also binds to ZO-2 [64] presents
the intriguing prospect that these ZO proteins, interacting with the
Cx43-PDZ-binding motif, compete to inﬂuence gap junctional pat-
terning. Conversely, a competition between Cx-partners of ZOs or
even between Cxs and proteins belonging to other classes of junction-
al complexes, tight junctions (ZO-1 was the ﬁrst TJ-associated protein
to be identiﬁed) (see [57]) or anchoring junctions (see [56]), still
widens the possibilities of adaptations of intercellular junctions to
the cell needs. However the fact that functional GJs are formed even
when the connexin/ZO-1 interaction is prevented (see [65]) indicates
that there are other mechanisms for plaque formation as well.
3.3. Tight junction associated proteins
Tight junctions are strands of transmembrane domain proteins of
apposed cells that interact across the extracellular space to provide
both barrier and fence functions, thereby limiting the ﬂow through
the extracellular space. Moreover, tight junction proteins help to po-
larize membrane compartments, leading to separated apical and
basolateral domains (for review, see [66]). Tight junctions are formed
by complexes of proteins including transmembrane proteins (includ-
ing claudins and occludins), cytoplasmic scaffolds (including ZO pro-
teins) that allow association with cytoskeletal elements and signaling
molecules (see [57]).
Occludin, a 65 kDa transmembrane phosphoprotein with a topol-
ogy similar to Cxs', was found to interact with Cx32 in immortalized
mouse hepatocytes [67] and cultured rat hepatocytes [68]. Nusrat et
al. [69], using a bait interaction system, noted that Cx26 interacted
with a coiled-coil domain of occludin. Claudins form a multigene
family (20 members; see [70]) of≈22 kDa transmembrane proteins
of the macromolecular tight junction complex, with also a topology
similar to Cxs'. Claudin-1 was found co-localized with Cx32, occlu-
din and ZO-1 at cell borders of rat hepatocytes lines. Association of
Cx32 with the tight-junction proteins was demonstrated by co-
immunoprecipitation [68]. Moreover, occludin, claudin-5 and ZO-1
were shown to co-localize and to coprecipitate with Cx40 and
Cx43 in porcine blood–brain barrier endothelial cells [71]. Multi-
PDZ domain protein 1 (MUPP-1), a tight junction-related protein
often co-localized with ZO-1 at tight junctions, was found co-
associated with Cx47 in homogenates of mouse brain and sciatic
nerve [72].
Thus, if gap junctions and tight junctions represent different types
of specialized plasma membrane microdomains, they however share
common adaptor molecules, particularly Zonula Occludens proteins,
and frequently present intermingled relationships where the differ-
ent proteins co-assemble into macromolecular complexes.
3.4. Anchoring junctions-associated proteins
The adhesive interactions between a cell and its surroundings play
a central role in regulating normal cell functions such as cell division,
migration, and differentiation by their coupling to signaling pathways
and to the cytoskeleton (for review, see e.g. [73]). During organformation, wound healing, tissue reorganization, and metastasis, cell
contacts are the subject of constant remodeling. Integrins, cadherins
and cell adhesion molecules (e.g. selectins) are transmembrane pro-
teins which mediate cell–cell and cell–matrix interaction and
communication.
Cadherins comprise an important family of transmembrane gly-
coproteins that mediate calcium-dependent cell–cell adhesion and
are linked to the actin cytoskeleton via catenins (see [74]). In
NIH3T3 cells, Cx43, N-cadherin and different N-cadherin-associated
proteins were co-localized and co-immunoprecipitated, suggesting
that Cx43 and N-cadherin are co-assembled in a multiprotein com-
plex containing various N-cadherin-associated proteins [75]. The
fact that GJ formation was disrupted in the presence of peptides
that compromise homophilic cadherin interactions suggests that GJ
might form preferentially between cell types that express the
same type of cadherins [76].
Catenins are multifunctional proteins which include α-catenin
and armadillo catenins, β-catenin, plakoglobin (γ-catenin, a primary
component of desmosomes and fascia adherens) and p120 catenin.
Plasma membrane-associated β-catenin acts as a component of cell-
adhesive junctions, and it was found co-localized and co-
immunoprecipitated with Cx43 in neonatal rat cardiomyocytes
[77,78]. In the latter study, β-catenin was suggested to associate
with α-catenin, ZO-1 and Cx43 during gap junction development. In
mouse neural crest cells, p120 catenin was found co-localized with
Cx43 and N-cadherin and, in preliminary studies in NIH3T3 cells,
Cx43 co-immunoprecipitated with one of the two p120 catenin
bands present [79].
In the epithelia of embryonic Drosophila, Inx2 interacts with core
proteins of adherens and septate junctions [80].
3.5. Membrane channels and receptors
Sodium channel complexes at intercalated discs (IDs) of ventricu-
lar myocytes are composed of tetrodotoxin-resistant Nav1.5 channels
closely associated with both N-cadherin and Cx43 [81]. Aquaporins
are water channel proteins belonging to the major intrinsic protein
(MIP) superfamily of membrane proteins; aquaporin-0 (AQP0), the
most abundant membrane protein in lens ﬁbers, was found to inter-
act with two binding sites within the intracellular loop region of
chick Cx45.6 [82] or of its human ortholog Cx50 [83].
In rat myocardium, Cx43 can interact (maybe indirectly) with
M2/M3 subtypes of acetylcholine seven transmembrane-domain
muscarinic receptors, and ischemia was found to speciﬁcally impair
this association [84]. Combining confocal microscopy and freeze-
fracture replica immunogold labeling, Rash et al. [85] observed, in
“mixed” (chemical plus electrical) synapses of goldﬁsh and rat
brain, a close proximity between Cx35 and a NMDA glutamate re-
ceptor subunit (NR1).
Receptor protein tyrosine phosphatases (RPTPs) form a family of
cell-surface receptors characterized by the diversity of their extracel-
lular domains, resembling some features of those present in several
cell adhesion molecules. However, in contrast to most of them,
RPTPs also contain one or two intracellular phosphatase catalytic do-
mains. RPTPs can bind to themselves (homophilic interactions) as
well as to other proteins (heterophilic interactions). The ﬁrst catalytic
domain of RPTPμ has been found to interact with the C-tail on Cx43 in
diverse cell systems; such interaction hypothetically might keep Cx43
in a non-tyrosine phosphorylated state, thereby preventing Src-
mediated channel closure [86].
Extracellular ATP binds to a plethora of ionotropic (P2X) and
metabotropic (P2Y) receptors, which mediate its action. The P2Y re-
ceptors (at least ten subtypes) are classical 7-transmembrane domain
metabotropic receptors coupled to G proteins. Upon ATP-binding,
P2X receptors (classiﬁed P2X1 to P2X7) undergo millisecond time-
scale transitions that lead to the open I1 state, allowing the passage
1850 J.-C. Hervé et al. / Biochimica et Biophysica Acta 1818 (2012) 1844–1865of Na+, K+, and Ca2+ through the channel pore. In P2X2, P2X4 and
P2X7 receptors, the gradual opening over seconds to minutes of a
larger pore that allows passage of molecules up to 900 Da is observed.
This second open state is referred to as open I2 state but the mecha-
nisms that underlie its opening still remain unclear. In one model,
the I2 state is proposed to be an intrinsic P2X property whereas in a
second one, it is thought to be due to the opening of junctional hemi-
channels built of connexins or pannexins. In mouse macrophages and
J774 cells, Cx43 and P2X7 receptors were found to co-localize and to
co-immunoprecipitate with the anti-Cx43 antibody pulling down
P2X7 [87]. Panx1 was seen to be co-immunoprecipitated with P2X7
receptors into HEK 293 cells [88] and cultured cortices of embryonic
rat [89].
3.6. Calmodulin
Calmodulin (CaM) now appears to be a constitutive or dissociable
Ca2+-sensing subunit of a surprising variety of ion channels found in
a wide range of species from Homo to Paramecium (for review, see
[90]). The ability of a non-speciﬁc CaM antagonist (triﬂuoperazine) to
prevent CO2-induced uncoupling of Xenopus embryonic cells led to
the suggestion that CaM may participate in channel gating [91]. This
hypothesis was strengthened by evidence for CaM binding to Cx32 in
gel overlays [92] and that a ﬂuorescent CaM derivative bound to Cx32
and Cx32 fragments in vitro [93]. With inhibition of CaM expression,
the slow gating and CO2-sensitive gating virtually disappearedwhereas
the expression of a CaMmutant (the N-terminal EF hand pair replaced
by a copy of the C-terminal pair) dramatically increased the chemical
gating sensitivity of gap junction channels composed of Cx32 and
decreased their sensitivity to transjunctional voltage [20], suggesting a
CaM participation in this mechanism.
Surface plasmon resonance assays with peptides corresponding to
different parts of another Cx, the Cx43, did not reveal molecular bind-
ing to CaM, but the authors suggested that interactions might occurTable 3
Reported interactions of connexins with enzymes.
Partner protein Via its Cx Cx motif
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a : bt: biochemical techniques (cell-free assays, chimeras, truncated connexins, mimetic p
ci: co-immunoprecipitation; fs: co-fractionation or co-sedimentation; dh: double hybrid; e
binding assays, surface plasmon resonance); nmr: nuclear magnetic resonance.
b : in roman characters, cells where Cxs were endogenously expressed; in italics, cells wvia other regions of the Cx43CT or indirectly [22]. In immunoprecipi-
tation assays, CaM has been found to interact with Cx50 but neither
with a truncated Cx50 (lacking the C-terminus) nor with C-
terminus, suggesting that CaM would not bind directly to C-
terminus, but would require the presence of some other part of
Cx50trunc, presumably the cytoplasmic loop (CL), to form a CaM, CT
and CL protein complex [94]. As emphasized by Harris [10], calcium
has a long and contentious history as a modulator of GJIC and might
have an indirect action via its interaction with calmodulin (as is the
case for different membrane channels; see [10]).
3.7. Enzymes
The C-tail of several connexins (e.g. Cx43) contains consensus
phosphorylation sites for several protein, and several connexins
have been shown to be substrates of several phosphorylation/de-
phosphorylation catalyzers, including tyrosine and serine/threonine
PKs (e.g. Src, Protein Kinases A (PKA), C (PKC) and G (PKG), Mitogen
Activated Protein Kinase (MAPK), cdc2 and casein kinase 1 and 2
(CK1 and 2)) and protein phosphatases (see for reviews [95–98]).
More stable interactions between some enzymes and connexins
have also been reported (see Table 3).
3.7.1. Protein kinases
3.7.1.1. Src protein tyrosine kinases. Regulation of Cx43 by Src has
been well documented. In vitro, Cx43 binds the SH3 domain of
v-Src, but not of c-Src, and mutations in the SH3 and SH2 domains
of v-Src as well as in the proline-rich region or tyrosine 265 of
Cx43, reduced interactions between v-Src and Cx43 in vivo [42].
In v-Src-transformed ﬁbroblasts, Cx43 appeared as an endogenous
substrate of pp60v-Src; this enzyme and Cx43 were partially co-
localized in regions of the plasma membrane and co-
immunoprecipitated, showing that the two proteins wereMain approachesa Cell typesb References
nmr [148]
at bt nmr [26]
ci Rat-1 cells, COS-7, A431, HeLa cells [100]
at Neonatal rat cardiomyocytes, HEK 293 [65]
ci at C57B16 mouse cortical astrocytes [101]
nmr [129]
ci Mouse cortical astrocytes [107]
nmr [148]
at bt nmr [26]
ci Rat Sertoli cells [205]
at ci Rat-1 ﬁbroblasts, HEK 293 cells, [42]
v-Src-transformed ﬁbroblasts
cl ci v-Src-transformed ﬁbroblasts [99]
cl ci Neonatal rat cardiomyocyte in culture [102]
Human cardiomyocytes [103]
cl ci fs N/N1003A cells, bovine lens cells [116]
cl ci Rat lens [104]
cl ci at TtT/GF cells [105]
ci NRK cells [267]
cl fs Rat adult rat [106]
ci Mouse cortical astrocytes [107]
cl bt at Mouse inferior olive [108]
cl ci at Goldﬁsh hindbrain [109]
cl ci fs Rabbit and human heart t issues [111]
TtT/GF cells [105]
ci Rat-1 cells, COS-7, A431, HeLa cells [86]
cl ci at nmr WB-F344 cells [112]
ci at bt HM1 embryonic stem cells [113]
eptides, oligomerization assays, chemical cross-linking tests, …etc.); cl: colocalization;
m: electron microscopy immuno labeling; at: afﬁnity techniques (pull-down, afﬁnity
here Cxs were exogenously expressed, surexpressed or mutated.
1851J.-C. Hervé et al. / Biochimica et Biophysica Acta 1818 (2012) 1844–1865associated in a stable complex [99]. Two different hypotheses for
Cx43 binding to c-Src have been put forward. Firstly, in cardiac
myocytes, constitutively active c-Src (Y527F) was able to phos-
phorylate Y-265 of Cx43-CT, and this phosphorylated residue be-
haved as a binding site for the c-Src SH2 domain, in parallel
with the disruption of the interaction of Cx43 with ZO-1 [65]. Sim-
ilarly, in other cell systems, the phosphorylation of Cx43 by c-Src
on Y-265 leads to loss of gap junctional communication, which
also could be rescued by the Cx43Y265F mutant [100]. Secondly,
an interaction between c-Src SH3 domain and polyproline se-
quences of the C-terminus of Cx43 was suggested to occur under
conditions of cellular stress (e.g. intracellular acidiﬁcation) in
mouse astrocytes, reversing ZO-1/Cx43CT binding and facilitating
Cx43 internalization [101].
3.7.1.2. Protein kinase C. Two PKC isoforms (PKCα and PKCε) are
known to localize to plasma membrane sites; in non-stimulated myo-
cytes of new-born rat, PKCε displayed a discontinuous pattern of lo-
calization at intercellular contact sites and partial co-localization
with Cx43. Treatment with FGF-2 or phorbol 12-myristate 13-
acetate (PMA, or 12-O-TetradecanoylPhorbol 13-Acetate, TPA) in-
duced a more continuous pattern of PKCε distribution, and the anti-
Cx43 staining appeared to overlap extensively with that of PKCε
[102]. In myocardium, both PKCα and PKCε co-localized with Cx43
[103]. In rat cardiomyocytes, PKCε but not PKCα co-precipitated
with Cx43 [102] whereas in human cardiomyocytes PKCα was also
present in the co-immunoprecipitate complex with either Cx43 or
PKCε antibodies [103]. In the latter study, recombinant PKCε or α in-
creased kinase activity signiﬁcantly in the co-immunoprecipitated
Cx43 complexes, but phosphorylation of puriﬁed human Cx43 by re-
combinant PKCα or ε resulted in only PKCε-mediated Cx43 phos-
phorylation. The TPA-induced activation of PKCγ caused its
translocation into membrane fractions, where it phosphorylated
Cx50 at serine and threonine residues and Cx46 only at threonine res-
idues; PKCγ, Cx46 and Cx50 then co-immunoprecipitated with
caveolin-1 [104]. In TtT/GF cells (a pituitary folliculo-stellate-like
cell line), contrarily to PKC-α, the atypical isoform ζ did interact
with Cx43 under basal conditions [105].
3.7.1.3. Other protein kinases. Myotonic dystrophy (DM) is a domi-
nantly inherited disease involving skeletal muscles, heart, endocrine
organs, lens and the central nervous system. The molecular basis of
this autosomal disorder has been identiﬁed as the expansion of a
CTG repeat in the 3′ untranslated region of a gene encoding a PK,
Myotonic Dystrophy Protein Kinase (DMPK). The pathophysiology
of the disease and the role of DMPK are still obscure. The main local-
ization sites of this enzyme are neuromuscular and myotendinous
junctions, terminal cisternae of the sarcoplasmic reticulum in the
skeletal muscle and at IDs in the cardiac muscle. In the last site,
DMPK was found co-localized with Cx43 both in the tissue and after
immunoblot analysis of partially puriﬁed GJ [106].
The disruption of Cx43 function is known to result from the activa-
tion of the downstream mitogen-activated protein (MAP) kinase (see
for example [97,98]); although the MAP kinases ERK1/2 did not inter-
act appreciably with Cx43 in control mouse cortical astrocytes, they
bound strongly (particularly ERK2) to Cx43 during chemical ische-
mia/hypoxia [107].
Cx36, the most common Cx at electrical synapses, interacts with
and is phosphorylated by the calcium/calmodulin (CaM)-dependent
protein kinase CaMKII [108], and Cx35, its ﬁsh ortholog, is also associ-
ated with CaMKII [109].
3.7.2. Protein phosphatases
These enzymes dephosphorylate phosphoproteins in order to reg-
ulate their function, thus the role of protein phosphatases is going to
be connexin isoform speciﬁc due to the fact that not all connexins arephosphoproteins. The major phosphoconnexin is Cx43, dephosphor-
ylable by two protein phosphatases, PP1 and PP2A (see [110]),
which co-localize and co-immunoprecipitate with Cx43 in several
cardiac preparations, such as normal and an arrhythmogenic rabbit
model of non-ischemic heart failure as well as human heart prepara-
tions [111]. Other protein phosphatases are also involved in reported
Cx interactions with RPTPs (see Section 3.5 above).
3.7.3. Other enzymes
3.7.3.1. Ligases. The ubiquitin protein ligase Nedd4 was shown by pull-
down assays to bind to the C-terminus of Cx43 and this observation
was conﬁrmed in vivo by co-immunoprecipitation and co-
localization experiments [112]. Tumor susceptibility gene 101
(TSG101), a human cellular protein belonging to a group of apparent-
ly inactive homologs of ubiquitin-conjugating enzymes, was found
associated with the C-tail of Cx45, -30.2, -36, and -43 in pull down an-
alyses and Cx31, -43 and -45 co-precipitated with endogenous
TSG101 protein in lysates from HM1 embryonic stem cells [113].
3.7.3.2. Synthase. Cx37 binds via its CT to a region of endothelial nitric
oxide synthase (eNOS), an enzyme of fundamental importance to
vascular biology and disease [114].
3.8. Proteins involved in intracellular protein trafﬁcking
Caveolins-1, -2 and -3 are a multi-gene family of 21–24 kDa inte-
gral membrane proteins; they act as scaffolding proteins to cluster
lipids and signaling molecules within the caveolae and sometimes
to regulate those proteins (including various membrane channels)
that are targeted to the caveolae. They are present in specialized
lipid raft domains, cholesterol-sphingolipid-rich microdomains that
function as platforms for membrane trafﬁcking and signal transduc-
tion. Caveolin-1 was found to associate with Cx43 [115,116]. In the
former study, some other connexins (Cx32, Cx36, and Cx46) were
also targeted to lipid rafts, while Cx26 and Cx50 were speciﬁcally ex-
cluded from these membrane microdomains.
PKCγ, as other conventional PKC isoforms, is cytoplasmic when in-
active; its activation by growth factors (e.g. IGF-1) or TPA can translo-
cate it from the cytosol to the membrane and allows it to interact with
and to phosphorylate Cx43. This leads Cx43, Cav-1 and PKCγ to redis-
tribute within the lipid rafts, resulting in a decrease in gap junction
plaques [116]. In rat epidermal keratinocytes, newly synthesized
Cx43 interacts with Cav-1 and Cav-2 in the Golgi complex, and they
seem to trafﬁc together to the plasma membrane in lipid rafts; once
at the cell surface, the majority of Cx43 dissociates from Cavs before
gap junction plaque formation [117].
3.9. Other protein partners of gap junction proteins
Additional protein partners of junctional proteins have been iden-
tiﬁed (see Table 4). A 150-kDa protein, named Cx43 Interacting Pro-
tein (CIP150), which associates with the juxtamembrane region in
the C-terminus tail of Cx43 was for example identiﬁed in different
cell types (HEK 293, HeLa, COS7 and NRK cells; [118]), a 85-kDa pro-
tein (CIP85) in HEK cells [119] and a 75-kDa protein (CIP75) in HeLa
cells [120]. In the latter case, it was noticed that Cx43 that immuno-
precipitated with CIP75 was not ubiquitinated [120].
Organ of Corti Proteins 1 and 2 (OCP1 and OCP2) are relatively
small acidic proteins predominantly expressed in the vertebrate audi-
tory system. OCPs (accounting for approximately 10% of the total pro-
teins found in the OC) are components of OC-speciﬁc ubiquitin
ligases, which presumably bind selected protein targets, positioning
them for ubiquitination. Cx26 can be co-immunoprecipitated from
extracts of the rat organ of Corti by immobilized anti-OCP1, implying
that OCP1 and Cx26 may associate in vivo [121] but no evidence was
Table 4
Reported interactions of gap junctional proteins with other partner proteins.
Partner protein Via its Cx Cx motif Main approachesa Cell typesb References
eNOS aa 843–854 Cx37 C-terminal bt ci at Neuro2A cells [114]
α- or β-tubulin Cx43 35 amino-acid domain
juxta-membrane region CT
cl fs at Rat-1 cells, COS-7, A431, MDCK, HEK 293,
T51B and human ﬁbroblasts
[52,53]
β-Tubulin Cx43 ci bt HL-1 cardiomyocytes, HeLa cells [217]
C-loop and C-terminal at ci HeLa cells [268]
F-Actin Cx30 cl ci HeLa cells [48]
Cx43 afm Embryonic rat astrocytes [49]
cl ci C2C12 cells. [51]
Panx1 C-terminal end ci fs BICR-M1Rk [47]
β-Actin Cx43 ci Mouse cortical astrocytes [107]
Drebrin Cx43 C-terminal ci at Vero cells, mouse astrocytes [50]
Cortactin Cx43 cl ci C2C12 cells. [51]
cl ci Mouse seminiferous tubules [269]
Consortin Cx43 ci at HeLa cells [157]
Vinculin Cx43 cl ci NIH 3 T 3 cells [79]
αII-s pectrin-SH3i Cx43 cl ci Rat and mouse myocardium [180]
Caveolin-1 aa 82–101,
aa 135–178




Cx43 cl ci fs N/N1003A cells, bovine lens [116]
cl ci fs U251 cells [270]
Cav-1, Cav-2 C-terminal cl ci Rat epidermal keratinocyte, HEK [117]
Caveolin-3 Cx43 cl ci dh bt Mouse heart tissue, HeLa cells [271]
β-Arrestin Cx43 C-terminal S368 bt cl ci Osteoblastic cell [207]
Ubiquitin Cx43 ci E36, BWEM cells [201]
ci IAR20 cells [202,203]
cl ci IAR20 cells [204]
CIP75 UBA domain Cx43 PY motif at the CT
(residues 264–302)
cl ci HEK 293, HeLa, MDCK,S180,
mouse ﬁbroblasts
[150]
cl ci at HeLa cells [120]
CIP85 SH3 Cx43 CT (a Proline rich region,
P253 LSP256)
ci dh HEK 293 cells [119]
CIP150 Cx43 CT (residues 227–242) dh at HEK 293, HeLa, COS7 and NRK cells [118]
OCP-1 Cx26 ci at Rat cochlea [121]
NOV Cx43 C-terminal cl ci at C6 cells, mouse astrocytes and
different human glioma cell lines
[124]
CT (residues 257–382) ci Jeg3 cells, HEK 293T cells [123]
Dlgh1 SH3/Hook Cx32 C-terminal and
cytoplasmic loop
cl ci dh at Mouse liver, SKHep cells [125]
BDIF-1 SH3 Cx43 C-terminal
(a Proline rich region)
cl ci HEK 293 cells [149]
Tom20, Hs p90 Cx43 ci Pig cardiac mitochondria [126]
ANT cl ci
Kvβ3 Panx1 cl dh Neuro2A cells [272]
a : bt: biochemical techniques (cell-free assays, chimeras, truncated connexins, mimetic peptides, oligomerization assays, chemical cross-linking tests, ...etc.); cl: colocalization;
ci: co-immunoprecipitation; fs: co-fractionation or co-sedimentation; dh: double hybrid; em: electron microscopy immuno labeling; afm: atomic force microscopy; at: afﬁnity
techniques (pull-down, afﬁnity binding assays, surface plasmon resonance); nmr: nuclear magnetic resonance.
b : in roman characters, cells where Cxs were endogenously expressed; in italics, cells where Cxs were exogenously expressed, surexpressed or mutated.
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mouse organ of Corti [122].
Nephroblastoma OVerexpressed (NOV) is a member of the CCN
(for CeﬂO/Cyr61 and Nov) family, a group of structurally related, se-
creted, extracellular matrix-associated proteins involved in diverse
biological processes like proliferation, differentiation, adhesion, mi-
gration and angiogenesis. NOV/CCN3, which may be involved in cell
cycle control (see [123]), was found to interact with the C terminus
of Cx43 [123,124].
Disks large homolog 1 (Dlgh1), the mammalian homolog of the
Drosophila disks large, is another MAGUK protein family which has
been suggested (see [125]) to down regulate cell proliferation. Cx32
was found to interact via its cytoplasmic loop and carboxyl tail with
the SH3/HOOK domain of Dlgh1 [125].
Cx43 was co-puriﬁed when pig cardiac mitochondria were sub-
jected to immunoprecipitation for Tom20 (Translocase of the outer
membrane 20), with Hsp90 (Heat shock protein 90) and with ANT
(Adenine Nucleotide Transporter). This led to the suggestion that
Cx43 interacted with the regular mitochondrial protein import ma-
chinery [126].4. Possible structural domains of junctional proteins involved in
interactions with partner proteins
4.1. Structural domains of connexins
Cx43 is the most ubiquitous and the most extensively studied
connexin; its large C-terminal domain, making a cytoplasmic fuzz
visible under electron microscopy, is likely to be relatively ﬂexible.
This carboxyl terminus is not required for formation of functional
channels but is critical for the regulation of GJIC. Intramolecular
particle–receptor interaction between the CT domain and the cyto-
plasmic loop, whereby amino acid residues of the cytoplasmic loop
act as receptor to which the CT can bind (“ball-and-chain” closure
mechanism, see Section 2), have been put forward for the regula-
tion of GJIC upon acidiﬁcation [22] or voltage difference (see
[127]). In the “cork-type” gating model proposed by Peracchia et
al. [20], a CaM lobe would physically obstruct the cytoplasmic
mouth of the channel pore. Apart from these intramolecular inter-
actions, the CT of Cx43 interacts with several partner proteins
(Fig. 1).
Fig. 1. Possible domains of Cx43 involved in interactions with partner proteins. Several domains of the C-terminal tail of the protein have been found involved in protein–protein
interaction with partner proteins.
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Except Cx36 (and its ﬁsh ortholog, teleost Cx35), which interacts
with PDZ-1 of ZO-1, Cxs (Cx30, -31.9, -43, -46, -47 and -50) mainly in-
teract with PDZ-2 of ZO-1 and, to a lesser extent, ZO-2; only Cx36 and
Cx45 have been found to interact with ZO-3 (see Table 2). Cx43 asso-
ciates with ZO-1 via its extreme CT; Jin et al. [128] suggested that this
interaction would take place through a typical Class II PDZ binding
domain. NMR titration experiments determined that the ZO-1 PDZ-
2 domain affected the last 19 amino acid residues of the CT of Cx43
[129]. Jin et al. [128] emphasized the fact that Cx31.9, Cx43, Cx46
and Cx50, in contrast with Cx32, exhibited similar PDZ binding motifs
(D-L-X-I) in their CT. Cx31.9 [130], Cx45 [131], Cx46 [132], Cx47 [133]
and Cx50 [134] also can interact with ZO-1 via their C-terminus
whereas Cx36 binds PDZ-1 of ZO-1 [135,136]. Cx36 indeed, in con-
trast with the ﬁrst connexin group, contains the C-terminus amino
acids Y-V, the binding motif domain present in the C-terminus of
most of the claudins and reported to be responsible for their interac-
tion with the PDZ-1 domain of ZOs [137]. A domain of 14 C-terminus
amino acids (and particularly the last 4 ones) of the Cx36 sequence
appeared to be required for Cx36 interaction with the PDZ-1 domain
of ZO-1 since a peptide corresponding to this region showed binding
capacity to the PDZ-1 domain of ZO-1 behaved as a competitive inhib-
itor of Cx36/ZO-1 interaction in vitro [135]. Sequence analysis and im-
munocytochemical data suggested that Cx36 might directly interact
with ZO-2 at mouse retinal gap junctions, but an indirect association,
via a partner protein (e.g. ZO-1) remained however possible [138].
ZO-1 binding by Cx43 was lost when phenylalanine residues were
substituted for 375Pro and 377Pro, showing that Cx43 localization to a
gap junction implies a speciﬁc structural conformation at residues
374Arg–379Asp that is also important for ZO-1 binding [139].
As ZO-1 was able to bind to a truncated Cx45 protein lacking the
canonical PDZ binding domain-binding present at the C-tail, Laing et
al. [140] suggested that Cx45 might have a large and complex binding
site for ZO-l, comprising the residues between amino acid 357 and the
Cx45 C-terminus, an alternative possibility being the existence of 2
distinct binding sites, one involving the C-tail and the second the
amino acids proximal to amino acid 360. The authors however did
not exclude either the possibility of an artifactual ZO-1/Cx45 bindingor of an indirect interaction (e.g. an association of Cx45 with Cx43
bound to ZO-1).
4.1.2. Calmodulin
To transduce changes in [Ca2+]i into diverse activities and func-
tion, CaM exhibit different speciﬁcities on binding to a wide range
of target proteins. According to Zhou et al. [141], subtle changes in
[Ca2+]I would be sensed by the “high-afﬁnity” C-domain of CaM, en-
abling it to preferentially interact with the intracellular loop of Cx
proteins whereas higher [Ca2+]I elevations would trigger the fully
open conformation able to completely inhibit GJIC, via a mechanism
not yet elucidated. Moreover, the molecular scenario of CaM effects
seems different for the α-class (Cx43, -44, -50) and the β-class
(Cx32), probably due to the fact that the α-class Cxs lack the NT gly-
cine hinge and possess longer intracellular loops and CT than the β-
class Cxs [142]. According to these authors, Ca2+-CaM interaction
with α-class Cxs would occur via a direct association with their intra-
cellular loop region. Török et al. [93] identiﬁed a high-afﬁnity CaM-
binding region in the NT of Cx32 that is absent in the lens Cxs
(Cx43, -46 and -50). In these Cxs, high-afﬁnity CaM-binding sites
have been identiﬁed, encompassing residues 138–157 for Cx43
[143], 132–153 for human Cx46 [141] and 141–166 in Cx50 [142].
These sequences, with conserved hydrophobic residues, are similar
to CaM-binding motifs found in different other proteins (e.g. calci-
neurin, adenylate cyclase, etc., see [142]).
4.1.3. Caveolin
Cx43 appears to interact with two distinct caveolin-1 domains, i.e.
the caveolin-scaffolding domain (residues 82–101) and the CT do-
main (135–178); a mutational analysis of Cx43 revealed that the hy-
pothesized PDZ- and presumptive SH2/SH3-binding domains within
the Cx43-CT were not required for this targeting event or for its stable
interaction with caveolin-1 [115]. Lin et al. [116] noticed that Cx43
has in residues 25–32 of the ﬁrst transmembrane sequence a perfect
consensus sequence for binding to a Cav-1 scaffolding domain. The
region surrounding S364 in the C-terminus was suggested to be in-
volved in the interaction of Cx43 with intracellular trafﬁcking pro-
teins [144].
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Cx43/v-Src association is mediated by interactions between the
SH3 domain of v-Src and a proline-rich region of Cx43 and by the
SH2 domain of v-Src and tyrosine 265 of Cx43 [42,145], and it was
suggested that such interaction might induce a structural change in
the C-terminus region of Cx43, thereby hindering the interaction be-
tween Cx43 and the ZO-1 PDZ-2 domain [65]. SH3 domains (50–70
amino acids long) possess three shallow pockets where the peptide
ligands bind. Two of the pockets are 2.5 nm long and 1 nm wide,
large enough to accommodate each of the prolines in the PxxP
motif, accompanied by a hydrophobic residue (i.e., A, I, L, V, and P).
Proline is indeed unique among the 20 common amino acids in hav-
ing the side-chain cyclized onto the backbone nitrogen atom. This
means that the conformation of proline itself is limited, with back-
bone angles of ~−65°. It also restricts the conformation of the residue
preceding the proline because of the bulk of the N-substituent and re-
sults in a strong preference for a β-sheet conformation. As a conse-
quence, polyproline sequences tend to adopt the PP II helix, which
is an extended structure with three residues per turn. This implies
that the two prolines in the SH3 domain ligand core, PxxP, are on
the same face of the helix and are thus well placed to interact with
the protein (see [146]). Such sequence-speciﬁc ability of proline-
rich regions to interact with other proteins might explain how a pep-
tide of the same sequence as amino acids 271 to 287 of Cx43
(CSSPTAPLSPMSPPGYK) can prevent pH gating of Cx43-expressing
oocytes [147]. As the Cx40-CT sequence does not content a consensus
PXXP binding motif, the SH3 domain of Src was proposed to interact
with domains rich in proline and/or positively charged residues of
Cx40-CT [148].
Alev et al. [108] identiﬁed 2 juxtamembrane cytoplasmic se-
quences of Cx36 that serve as potential binding sites for CaMKII and
proposed a model of mechanistic framework for CaMKII/Cx36 inter-
action. Upon local Ca2+ elevation, Ca2+/CaM would bind to the auto-
inhibitory domains of CaMKII, allowing the cytoplasmic loop binding
site of Cx36 to interact with the catalytic site of the kinase.
4.1.5. Other protein partners
The Cx43 35-amino acid juxtamembrane region is necessary and
sufﬁcient for tubulin binding. This motif (234KGVKDRVKGK243, resi-
dues typically found in tubulin binding domains are underlined) is
unique for Cx43 and was not found in the sequence of other connexin
family members [52]. CIP150 was shown to associate with the region
corresponding to 16 amino acids in the juxtamembrane region in the
CT tail of Cx43 (amino acids 227–242; [118]) whereas CIP85–Cx43 in-
teraction would depend on the SH3 domain of CIP85 and a proline-
rich region of Cx43 (253PLSP256; [119]). The proline-rich regions of
Cx43 (253PLSP256, 274PTAPLSPMSP283) also appear to exhibit particu-
lar afﬁnity and selectivity toward SH3 domains, and Cx43 was found
to interact with BDIF-1 (Brain-Derived Integrating Factor-1; [149]).
CIP75, which contains an ubiquitin-associated (UBA) domain at its C
terminus and an ubiquitin-like (UBL) domain at its N terminus, was
found to interact with Cx43 via its UBA domain [150].
The growth regulator NOV (CCN3) directly interacts with the C-
terminus of Cx43 [124] in the region between amino acids 257 and
382 [123]. The interaction of Cx43 with Nedd4 involves all three
WW domains of the latter; furthermore, whereas WW1 and WW2
domains mainly interact with the unphosphorylated form of Cx43,
WW3 binds phosphorylated and unphosphorylated forms equally.
In addition, the surface plasmon resonance approach revealed that
only the WW2 domain binds to the PY motif located at the C-
terminus of Cx43 [112]. A peptidic sequence homologous to a region
of endothelial nitric oxide synthase (eNOS), an enzyme of fundamen-
tal importance to vascular biology and disease binds to Cx43-CT
[114].
In the dual model proposed by Alev and co-workers [108] for
CaMKII-Cx36 interaction, the binding of Ca2+/CaM to CaMKII wouldallow the interaction of CaMKII with the cytoplasmic loop of Cx36,
triggering CaMKII autophosphorylation, leading to binding of the ac-
tivated kinase to a CT-site of Cx36.
Truncation experiments of Cx32 suggested that a crucial gap-
junction targeting sequence resides between amino acid residues
207 and 219 on the cytoplasmic C-tail [151]. In hepatocytes from
Cx32-deﬁcient mice transfected with Cx32, Cx26, or Cx43 cDNAs, en-
dogenous occludin was in part localized at cell borders, co-localized
with Cx32, whereas neither was detected in parental cells nor in
Cx26 or Cx43-transfected cells. Several amino acid sequences in
Cx32 were proposed as CaM-binding motifs, including residues
1–21 (NT) and 216–230 (CT) [93] and parts of the third transmem-
brane domain and of the CT-tail [152]. 175Asparagine of Cx32 was
proposed to be a critical residue for docking and forming functional
heterotypic gap junction channels with Cx26 [153].
4.2. Structural domains of innexins
Inx2 and Inx3 form heterodimers in vivo in Drosophila embryos,
with a binding of CT of Inx2 to the CT of Inx3 [33]. Moreover, in con-
trast to the selective binding behavior of the Inx2 C terminus, the CT
of Inx3 has the potential to interact more broadly (e.g. to heteromeri-
cally interact with the cytoplasmic loop domain of Inx2). RNA apta-
mers capable of binding to a proximal epitope on the CT of Inx2
speciﬁcally inhibited the heterologous interaction of Inx2 and Inx3
CTs in vitro [154].
5. Functional importance of protein–protein interactions
5.1. Channel functions
A model for gap junction formation has progressively emerged
from biochemical and cell biological studies. The constituent proteins
of gap junctions are, as many other integral plasma membrane pro-
teins (for example other channels, other intercellular junctions or dif-
ferent membrane receptors) renewed several times a day (for review,
see [155]). Potential interacting partners (including cytoskeletal pro-
teins, scaffold proteins, enzymes, etc.) play important roles in correct
subcellular localization of gap junction channels and in functional
regulation of gap junction-mediated intercellular communication:
5.1.1. Synthesis, transport to the plasma membrane and insertion of
proteins
Connexins enter the secretory pathway and are delivered to the
plasma membrane by way of the endoplasmic reticulum and the
Golgi complex; evidence have however been brought that Cx26 can
reach the cell surface via a Golgi-independent pathway (see for ex-
ample [156]). del Castillo et al. [157] identiﬁed consortin as the ﬁrst
potential trans-Golgi network cargo receptor for the sorting and cell
surface targeting of transmembrane proteins, able to simultaneously
interact with the connexins to be sorted and with the adaptor
machinery.
Microtubules are highly dynamic cytoskeleton structures formed
through the polymerization of α- and β-tubulin dimers elongating
existing microtubules and have a well-studied role in the targeted
Cx43 delivery at the cell membrane [76,158–160]. Individual micro-
tubules typically emanate from the microtubule organizing centers
(MTOCs, e.g. centrioles or basal bodies), anchored via their “minus”
ends. The microtubule polarity is important for protein transport
since the motor proteins kinesin and dynein typically slide preferen-
tially in either the “plus” or “minus” direction, respectively, along the
microtubule, allowing vesicles to be directed to or from the endoplas-
mic reticulum and Golgi apparatus. Shaw et al. [76] proposed a model
of direct targeting of hemichannels to cell–cell junctions in which the
microtubule plus-end-tracking protein EB1 (able to co-
immunoprecipitate with Cx43) binds, via its C-terminus, to
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with adherens junctions through direct binding with β-catenin. In in
vitro assays using isolated Cx32-containing vesicles from rat hepato-
cytes able, when stimulated by the addition of ATP, to move along
the microtubules, Cx32 and kinesin motor proteins were found in
the same vesicles [161]. In the model proposed by Rhett et al. [162],
adherens junctions nearby to GJs might act as sites of preferential de-
livery of connexons to nonjunctional plasma membrane proximal to
GJs.
ZO proteins are at the center of a network of protein interactions,
linked to the actin cytoskeleton via their CT, to Cxs via their NT. In the
mouse retina for example, ZO-1, interacting with Cx45 via its PDZ-2
domain and with Cx36 via its PDZ-1 domain, provides for co-
scaffolding of Cx45 with Cx36, forming “bihomotypic” gap junctions,
with Cx45 structurally coupling to Cx45 and Cx36 coupling to Cx36
[163]. The critical role of ZO-1 in mediating this association by tether-
ing the two Cxs within gap junctions was indicated by abolition of
Cx36/Cx45 co-IP after removal of the C-terminal 4 aa residues of
Cx36, required for the interaction of Cx36 with the PDZ-1 domain of
ZO-1 [163]. The fact that ZO-1 and ZO-2 seem to compete throughout
the cell cycle for association with Cx43 led Singh et al. [64] to suggest
that the ratio of ZO-1 and ZO-2 interacting with Cx43 may inﬂuence
the stability and/or stabilization of gap junctions. As ZO-1 can target
to the periphery of Cx43 junctional plaque independently of PDZ-2-
mediated interactions, Hunter and Gourdie [164] put forward a tar-
geting sequence that would initially involve ZO-1 bound to junctional
complexes (possibly N-cadherin-based) adjacent to GJs, followed by a
transfer of ZO-1 and its direct engagement with Cx43 at GJ edges. In
Cx43-HeLa cells, actin co-immunoprecipitated with ZO-1 only in the
Triton-insoluble fraction, suggesting that ZO-1, actin and Cx43 were
present in the same multiprotein complex only when connexons
were aggregated in detergent-resistant GJs [162].5.1.2. Cellular selectivity of gap junction formation
The de novo formation of a GJ plaque, its growth and disassembly
are still poorly understood. A connexon present in the plasma mem-
brane docks with a connexon in the contiguous cell membranes to
form an intercellular channel and a GJ plaque is formed when several
intercellular channels cluster.
The extracellular domains of connexons may also dock with con-
nexons of adjoining cells and thereby link adjacent cells independent-
ly of channel formation, through a mechanism similar to cell adhesion
molecules (CAMs) [165–168].
Nevertheless, a close proximity between the plasma membranes
of neighboring cells mediated by anchoring junctions facilitates GJ
formation and an intimate linkage between gap junction and adhe-
rens junction formation has frequently been reported (for review,
see [169]). Cadherins are generally regarded as the main driving
force of self-assembly. In human squamous carcinoma cells, E-
cadherin-mediated cell–cell adhesion facilitated the growth and as-
sembly of only preformed GJs but was not sufﬁcient to trigger the as-
sembly of GJs de novo [170]. In rat liver epithelial cells, antagonist
effects of E-cadherin and N-cadherin on the assembly of Cx43 into
GJs (with E-Cadherin facilitating and N-Cadherin inhibiting the as-
sembly) were observed [171].
However, full lateral overlap of cadherin transdimers requires a
distance of 20–25 nm between contiguous plasma membranes [172]
whereas connexons only protrude very slightly (see [173]) from the
membrane surface, the intercellular space being 2 to 3 nm wide. In
lens ﬁbers, interaction between the extracellular loop domains of
two apposing AQP0 molecules were proposed to allow the formation
of 11–13 nm thin junctions [174].
Liu et al. [83] observed that AQP0 interaction with Cx50 (the
human ortholog of chick Cx46.5) enhanced gap junction coupling
and hypothesized that the cell-to-cell adhesion function of AQP0might serve to increase the proximity of adjacent cells, enhancing
the probability of connexon docking.
5.1.3. Opening of intercellular channels
The mechanisms of connexon assemble to form intercellular chan-
nels are also still poorly understood and involve interactions between
the extracellular loops. Unapposed hemichannels, able to open under
certain conditions, must remain closed most of the time to maintain
the plasma membrane permeability barrier. The opening of the
“loop gates”when hemichannels dock allows a transition to the junc-
tional conﬁguration. The second extracellular loop would be a partic-
ularly important determinant of heterotypic compatibility [10,175].
Ahn et al. [176] observed that if deleting most of its CT did not pre-
vent Cx32 from forming functional channels, to substitute the intra-
cellular loop and/or tail of Cx32 with those of Cx29 prevented Cx32
from forming functional gap junctions. Cx33, a Cx speciﬁcally
expressed in the testis, was seen to form with Cx43 a complex that
was sequestered in the intracellular compartment within early endo-
somes, causing a marked inhibition of GJIC between Sertoli cells
[177].
5.1.4. Localization of gap junction plaques
Cytoplasmic scaffold proteins appear to play key roles in the as-
sembly of membrane specialized areas (e.g. cellular junctions, chan-
nel or receptor clusters, etc.), organizing membrane proteins into
specialized membrane domains. Cytoskeletal-based perimeter fences
were for example seen to selectively corral a membrane-protein sub-
population of potassium channels (Kv2.1 channels) to generate stable
1–3 μ2 clusters [178]. These authors noticed that despite the stability
of these microdomains, the channels retained within the cluster pe-
rimeter were surprisingly mobile, showing that the clustering did
not result from a static scaffolding-based structure. Connexin chan-
nels clustered in gap junctional plaques share these characteristics,
where ZO-1 is preferentially localized at the periphery of the Cx43
[61–63], or Cx50 [179] plaques, suggesting that a ZO-1-actin perime-
ter fence could selectively corral gap junction channels. ZO-1 might
act as part of a dynamic mechanism for apportioning connexons be-
tween free hemichannels and GJs [162].
In some cell types, gap junctions are preferentially located in spe-
ciﬁc membrane areas; in adult heart for example, Cx43 gap junctions
localized to the IDs of myocytes.
The link between Cx43 and α-spectrin, via ZO-1, was suggested
to serve to localize Cx43 at the cardiac IDs [59]. Ursitti et al. [180]
observed an interaction between Cx43 and a particular alternatively
spliced isoform of αII-spectrin containing a 20-amino-acid insert ad-
jacent to its SH3 domain and suggested that the localization of Cx43
to gap junctions would require the αII-SH3i form of αII-spectrin and
that this activity would be regulated by the JNK pathway. The cyto-
skeletal adaptor protein Ankyrin-G (AnkG) might act as organizing
center of subcellular microdomains, clustering protein complexes
of complementary function, as, at cardiac IDs, Nav1.5, the desmo-
somal component PKP2, and Cx43 [181].
A molecular mechanism of Cx43 lateralization was for example
proposed by Kieken et al. [182], where intracellular acidiﬁcation
caused by coronary occlusion led to Phospho-c-Src translocation to
the ID, allowing its interaction via its SH3 domain with the PDZ-2
domain of ZO-1, as well as 2 additional lower-afﬁnity Cx43CT do-
mains, causing displacement of the Cx43CT from ZO-1. This enabled
Cx43 to move in the membrane lipid bilayer from the ID to the lat-
eral membrane, causing decreased conduction velocity and forma-
tion of an arrhythmogenic substrate.
5.1.5. Properties of gap junctional channels
The formation of GJ channels by two or more Cxs enables cells to
produce channels that have unique permeability and gating charac-
teristics that could not be obtained using a single Cx [127,183,184].
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heterotypic channels with different connexins (see for example [10]),
but the reported cases in native cells are still in limited number (see
Table 1).
5.1.6. Modulation of junctional channel activity
Ca2+, the ﬁrst identiﬁed agent able to cause a “decoupling of the
highly permeable intercellular bridges” [185] was proposed to act
via CaM, through an interaction between Ca2+-bound CaM and one
or more intracellular domains of Cxs [20,91,186]. How CaM controls
the chemical gating of hemichannels or intercellular channels is not
yet understood, but Dodd et al. [186] proposed a CaM-Cx32 model
of interaction via a trans-domain or trans-subunit bridging. A “cork-
type” gating was also proposed for Ca2+-CaM-induced inhibition of
GJIC mediated by the lens Cx43 [143], Cx44 [141] and Cx50 [142].
Reversible and dynamic protein phosphorylation is a pivotal
mechanism in the regulation of essentially all cellular functions, in-
cluding GJIC, but the precise mechanisms remain unclear. The anchor-
ing of involved enzymes at speciﬁc subcellular sites is critical for their
functioning. The fact that junctional channel activity is well preserved
during intracellular cell dialysis (in conventional whole cell mode of
the patch-clamp technique (see [187])) and even after membrane ex-
cision (when the membrane of one of the cells is mechanically rup-
tured whereas the second cell is investigated; [188]) shows that
enzymes important in the regulation of the channel permeability
are ﬁrmly anchored in the channel vicinity. In the scaffolding model
proposed by Laing et al. [189], the different domains of ZO-1 serve
as docking modules for enzymes (e.g. PKs and PPs), localizing them
in the vicinity of junctional channels. The balance between Cx43/c-
Src and Cx43/ZO-1 associations for example may inﬂuence the activ-
ity of junctional channels.
However, this GJIC modulation is much more complex than direct
connexin phosphorylation and increasing evidence indicates that
protein partners are involved. This view is supported by a lack of cor-
relation between the degree of junctional coupling and the pattern of
Cx43 or Cx45 phosphorylation, suggesting that the participation of
additional regulatory component is required (for review, see [96]).
However, several associations of Cxs with protein partners were
found to depend on the phosphorylation status of Cx43, as the bind-
ing of c-Src to Cx43 (blocked by inhibition of Cx43 dephosphoryla-
tion; [107]) or the interaction between Cx43 and the rat Nedd4
domain WW3 and possibly that of domain WW1 (prevented by the
speciﬁc phosphorylation of Cx43 at S279 and S282; [112]).
Several stimuli (for example ischemia, oxidative stress, activation
of tyrosine kinases, of different PKC isotypes, of the MAP kinase sig-
naling pathway, etc.) frequently lead to an interruption of the GJIC
very likely by affecting the association between connexins and their
protein partners, with consequences on the strength of intercellular
coupling (for detailed review, see for example [190]). More recently,
Cx43 interaction with the atypical PKC-ζ was found in TtT/GF cells
to be reduced by acute treatment with TNF-α, causing a transient
intercellular uncoupling, showing that TNF-αmaintained the enzyme
apart from Cx43 to prevent the phosphorylation of Ser368 [105].
Consequences of the binding of the c-Src SH3 domain to Cx43 and
to Cx40 differ on the interactions of these Cxs with ZO-1. It can indeed
disrupt the Cx43/ZO-1 interaction, leading to down-regulation of GJIC
[65,101,129] whereas it did not affect the Cx40-CT/ZO-1 PDZ-2 do-
main complex [148].
Cx43-based cell-to-cell communication between Rat-1 ﬁbroblasts
was seen to be inhibited by depletion of phosphatidylinositol 4,5-
bisphosphate (commonly known as PIP2), a compound functioning
as an intermediate in the inositol 1,4,5-triphosphate and diacylgly-
cerol (IP3/DAG) pathway, which is initiated by ligands binding to G
protein-coupled receptors activating the Gαq subunit. PIP2 is a sub-
strate for hydrolysis by phospholipase C (PLC). Inhibiting PIP2 hydro-
lysis kept Cx43 channels open after receptor activation [191]. As ZO-1binds directly to the very C terminus of PLCβ3 via its third PDZ do-
main, it was proposed to be a key intermediate in assembling Cx43
and PLCβ3 into a complex, thereby facilitating regulation of Cx43
channel function via PIP2 hydrolysis upon receptor activation [191].
Compared to cells where only one pannexin is expressed, the
combination of Panx1 and Panx2 resulted in a reduced dye uptake
in 293T cells [34].
5.1.7. Degradation of gap junctions
The strength of cell-to-cell communication is regulated by the gat-
ing of the channel pore but largely depends also on the number of
intercellular channels present in gap junction plaques. Newly formed
channels are constantly being added to the periphery of existing pla-
ques whereas older portions are internalized from the center of the
plaque (see [192]). Several of connexin partners have been reported
to contribute to the degradation of junctional plaques, particularly:
5.1.7.1. ZO-1. Earliest observations had revealed that gap junction
fragments were degraded by internalization of a double-membrane
structure called “annular junction” into one of the two cells, where
subsequent lysosomal or proteasomal degradation occurred, except
in some cases where the connexons were recycled. Elements of the
actin cytoskeleton were seen closely associated with annular junc-
tions [193]. ZO-1 was suggested to confer speciﬁcity to actin-based
contractile processes via its ability to simultaneously interact with
Cx43 and cytoskeleton [194]. In 42GPA9 Sertoli cells, Gilleron et al.
[195] noticed that if ZO-1 was usually localized on both sides of the
gap junction plaque, its presence became restricted to one side of
the junctional plaque during the endocytic GJ internalization and
the formation of annular junctions, suggesting that the dissociation
of ZO-1 from Cx43 – preferentially on one side of the junctional pla-
que – had a prominent role in GJ endocytosis. In HeLa cells stably
expressing tagged Cx43 (Cx43-YFP, Cx43 tagging being known to pre-
vent ZO-1 binding), GJ internalization did not occur in response to in-
ﬂammatory mediators, showing that ZO-1-Cx43 interaction is
required for GJ internalization [196].
c-Src appears involved (via modiﬁcations in the Cx43/c-Scr/ZO-1
complex) not only in the modulation of the functional state of junc-
tional channels [101,107] but also in the stability of GJ plaques, facil-
itating the GJ internalization [101,107,195] and subsequent
degradation of annular junctions [197]. According to Akoyev and
Takemoto [198], the close proximity of the 368Ser/PKCγ phosphoryla-
tion site to the PDZ/ZO-1-binding domain on the Cx43-CT suggests
that ZO-1/Cx43 effects and PKCγ effects may be connected, ZO1
being able to modulate the interaction of PKCγ with Cx43 and, thus,
the PKCγ-driven gap junction disassembly of Cx43.
5.1.7.2. Ubiquitin and/or partners. Attachment of ubiquitin to cellular
proteins is a major post-translational modiﬁcation that can have pro-
found effects on protein stability, localization or interaction pattern
(for references, see [192]). Conjugation of ubiquitin is a complex en-
zymatic process that leads to the formation of an isopeptide bond be-
tween the C-terminal Gly of ubiquitin and the ɛ-amino group of a Lys
residue of the substrate protein [199]. Due to the presence of internal
Lys residues, ubiquitin can repeatedly be attached to itself, forming
chains with various topologies and functions. Attachment of a single
ubiquitin marks substrate proteins for degradation in lysosomes
whereas polyubiquitination targets the substrate to the proteasomal
pathway [200]. The mechanism of proteasomal degradation of con-
nexins is still poorly understood; adaptor proteins might bind both
Cx43 and a proteasomal component (see for example [150]).
Sequential immunoprecipitation using anti-Cx43 and anti-
ubiquitin antibodies demonstrated polyubiquitination of Cx43 in cul-
tured E36 hamster cells [201]. To discriminate whether Cx43 was
mono- or polyubiquitinated in response to TPA treatment, Leithe
and Rivedal [202] used antibodies that differentiate between different
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Cx43 was monoubiquitinated rather than polyubiquitinated in re-
sponse to PKC activation.
CIP75, able to interact with Cx43 (via its UBA domain) and with
subunits of the proteasome complex (through its UBL domain) had
been proposed to function as an adaptor or shuttle factor in the deg-
radation of Cx43 via the proteasomal pathway [150]. However, in
subsequent observations from the same group, CIP75, despite the
fact it is an ubiquitin-binding protein, did not appear to interact
with ubiquitinated Cx43, as if Cx43 was one of the rare cases of
non-ubiquitinated proteins targeted for proteasomal degradation
[120]. In the model proposed by these authors, CIP75 would interact
with non-ubiquitinated Cx43 in the ER and then acts as a shuttle to
transport Cx43 from the ER to the proteasome for degradation.
TSG101 might also be involved in the proteasomal degradation of
connexins [113]. The CIP85-Cx43 interaction was reported to stimu-
late the degradation of Cx43 through a currently unknown mecha-
nism involving the lysosomal pathway [119]. The EGF- and TPA-
induced degradation of Cx43 was found to be preceded by Cx43 ubi-
quitylation [203–272]. Ubiquitin recruitment was particularly pro-
nounced in gap junction regions that were in the process of
internalizing into one of the adjacent cells [204]. After PKC activation,
entire gap junction plaques were, in IAR20 cells, sometimes coated
with ubiquitin, suggesting that internalization of junctional plaques
would not only concern the center of the plaque as previously ob-
served [158], but also its periphery [204].
5.2. Importance in protein partner activities
Several gap junction proteins, besides their role as pore-forming
subunits, mediate gap junction- and hemichannel-independent ef-
fects in cell growth, differentiation, tumorigenicity, injury, and apo-
ptosis, but the mechanistic aspects of such actions still remain
largely unknown. One plausible mechanism would be regulating ef-
fects of GJ proteins through their interactions with partner proteins
(for detailed review, see for example [190]).
5.2.1. Importance in expression, localization and activity of partner
proteins
The organization of metazoa is based on the formation of tissues
made of individual cells connected by different structures (intercellu-
lar junctions) made of densely packed transmembrane proteins
linked to proteins anchored on cytoskeleton ﬁlaments. The different
intercellular junctions frequently present intermingled relationships
where the different proteins co-assemble into macromolecular com-
plexes and their expressions are co-ordinately regulated (see [169]).
The connexon-mediated cell adhesion may play in microtissue self-
assembly a role comparable to that of cadherins, and cells expressing
chimeric connexins capable of docking, but not channel formation,
show no change in their ability to migrate or adhere (see [168]). In
the rat embryonic cerebral cortex for example, gap junctions do not
mediate neuronal migration via their channel properties but provide
dynamic adhesive contacts that interact with the internal cytoskele-
ton to enable leading process stabilization along radial ﬁbers as well
as the subsequent translocation of the soma [166].
Cx43 and plakophilin-2 (PKP2) form a protein complex within the
desmosome-like junction to regulate cell adhesion at the blood-testis
barrier (BTB) formed by adjacent Sertoli cells. BTB is regarded as one
of the tightest blood–tissue barriers in mammals but must however
undergo extensive restructuring to allow the transit of primary sper-
matocytes (see [205]). The knockdown of both Cx43 and PKP2 caused
redistribution of occludin and ZO-1 from the cell-cell interface and
perturbation of the barrier function of the Sertoli cell tight junction
[205]. Cx43 was suggested to be responsible for the necessary cross-
talk between different junction complexes to maintain their adhesive
function and to coordinate them to maintain the immunologicalbarrier integrity during the spermatocyte transit [206]. Downregula-
tion of Cx37 by Cx37 antisense leads to an increased nitric oxide
(NO) production [114].
The inter-dependency of junctional multiprotein complexes is for
instance illustrated by the fact that subcellular targeting of MUPP-1 as
well as Cx32 and ZONAB (ZO-1-associated Nucleic Acid Binding pro-
tein) to mouse oligodendrocyte gap junctions required the presence
of Cx47, which is also necessary for assembly and maintenance of
Cx43 at oligodendrocyte/astrocyte gap junctions [72].
Systemic elevation of parathyroid hormone (PTH) leads to a po-
tent bone anabolic effect, except in mice lacking Cx43, the most abun-
dant Cx expressed in bone cells (see [207]). Cx43 expressed in
osteoblasts was proposed to sequester a pool of β-arrestin by interac-
tion with its phosphorylated S368, allowing PTH-dependent pro-
survival signaling downstream of cAMP. PTH would induce Cx43 de-
phosphorylation (likely by activating protein phosphatases), leading
to the release of β-arrestin. Free β-arrestin would then bind to the
PTH Receptor-1 (PTHR1), causing inhibition of cAMP production,
and internalization of PTHR1. In Cx43-deﬁcient osteoblasts, a larger
pool of β-arrestin is available to bind to PTHR1, thus blunting cAMP
accumulation, transcription of cAMP target genes, and survival signal-
ing induced by PTH [207].
Purinergic signaling plays particularly important roles in paracrine
signaling, which allows multiple cells within a tissue to actively re-
spond to environmental stresses (as metabolic inhibition, mechanical
shear or microbial invasion for example) sensed by only a few cells at
the site of environmental insult or stimulation. Panx1 appears as the
molecular substrate of a large pore activated by either metabotropic
P2Y [208] or ionotropic P2X7 [88,209–212] receptors, allowing the
diffusion of molecules up to 900 Da.
In cardiac IDs, according to Sato et al. [181], desmosomes, gap
junctions and sodium channels would not be independent but rather
act as a “functional triad” where changes in composition of one could
affect the function and integrity of the other, with signiﬁcant conse-
quences to electric cardiac synchrony.
5.2.2. Transcription regulation
ZOs, associated in junctional multiprotein complexes, are also
known to be engaged in the transmission of signals from the plasma
membrane to the nucleus to regulate gene expression. ZO-1 is associ-
ated with the transcription factor ZONAB [213], ZO-2 with the tran-
scription factors Jun, Fos and C/EBP [214]. The binding of
transcription factors to ZO-1 results in their membrane sequestration
at intercellular junction level and hence the inhibition of their tran-
scriptional activity.
Haplodeﬁcient mice expressing a CT-truncated Cx43, incompetent
to interact with ZO-1, formed GJs at cardiac IDs that were larger than
those observed in wild-type litter mates [215]. siRNAs used to knock
down ZO-1 levels caused an unchecked accretion of undocked con-
nexons at the plaque periphery, resulting in larger GJs and fewer
hemichannels [162]. Knocked down expression of ZO-1 was also
seen to reduce Cx43 expression in human trophoblasts (with result-
ing lessened cell–cell fusion and differentiation [216] and GJ forma-
tion in human squamous carcinoma A431D cells [170]).
Smads are intracellular proteins that transduce extracellular sig-
nals from transforming growth factor-β (TGF-β) ligands to the nucle-
us where they activate downstream TGF-β gene transcription.
Smad2/3 binds to β-tubulin; Cx43 competing with Smad2/3 for bind-
ing to microtubules would induce Smad2/3 release from microtu-
bules, causing, via the formation of a complex with a co-mediator
Smad (Smad4), a translocation to the nucleus, where Smad2/3 and
Smad4 accumulate, leading to activation of the transcription of target
genes [217].
In mice cortical astrocytes, Iacobas et al. [218] observed that genes
encoding gap junction protein and purinergic receptors were coordi-
nately expressed and were also coordinately expressed with a
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nases. Immunoprecipitation assays and antibody array studies con-
ﬁrm interactions between certain of these participants, allowing
these authors to propose a model of supramolecular complex where
GJ and purinergic P2 receptor form functional units.
6. Roles of protein–protein interactions
The interactions between gap junction proteins and their protein
partners (e.g. scaffolding proteins, cytoskeletal proteins, protein ki-
nases and phosphatases), membrane receptors strongly inﬂuence
the subcellular localization of junctional components and their func-
tional state.
6.1. Cellular growth control and cancer
Besides the transmembrane diffusion of small molecules and me-
tabolites that support tissue homeostasis and electrical and chemical
signaling, gap junction proteins are, via their selective protein–pro-
tein interactions, involved in the control of cell growth, proliferation,
apoptosis, and would serve as tumor suppressors. In the model pro-
posed by Solan and Lampe [219] for example in normal rat kidney
cells during their progression from G0/G1 through S phase and into
mitosis, Cx43 is at ﬁrst found predominantly at the plasma mem-
brane, assembled into “typical” gap junction plaques, associated
with both ZO-1 and ZO-2, at the plasma membrane. Then the assem-
bly of Cx43 into plaques becomes less efﬁcient, accompanied by a
shift in subcellular Cx43 localization and a decreased co-localization
with ZO-1 while the ZO-2 interaction was maintained. When cells
enter mitosis, GJIC is interrupted and Cx43 is predominantly intra-
cytoplasmic [219].
Heteromerization of Drosophila Inx2 and -3 is crucial for epithelial
organization and polarity of the embryonic epidermis, and Inx3 is
mislocalized to the cytoplasm in Inx2 mutants and is recruited into
ectopic expression domains deﬁned by Inx2 misexpression [33].
Cancer was the ﬁrst pathology associated with gap-junction defect
[220] but, in spite of the evidence accumulated since then, the molec-
ular involvement of gap junctions and their structural proteins in can-
cer has not been elucidated. The lack of a satisfying explanation may
come from the complexity of this disease, evolving through various
stages during tumor progression, with cancer cells exhibiting differ-
ent phenotypes (for recent review, see for example [221]). Several Ar-
madillo catenins known as connexin partners are highly implicated in
tumor progression both by their malfunction as adapter proteins
(linking cadherins to the belt of actin ﬁlaments in adherens junctions
but also by their role in regulating gene expression (see for example
[222])). As emphasized by Duffy et al. [125], there is increasing evi-
dence of connexin involvement in the modulation of transcriptional
activity via two pathways, either a translocation of a part of Cx mole-
cules (e.g. their CT) to the nucleus or their interaction with proteins
with transcriptional activity. The latter mechanism has for example
been proposed for Cx43 interaction with transcription regulators as
NOV [123,124] or transcription factors as ZONAB, Jun, Fos or C/EBP
(see for example [223]).
6.2. Cell motility
Gap junctional proteins, associated with scaffolding proteins an-
chored to the cytoskeleton form multiprotein complexes, providing
dynamic intercellular adhesive contacts particularly important for
processes such as cell migration, recently reviewed by Olk et al.
[224]. Dynamic adhesive interactions of connexins with the internal
cytoskeleton may then play in cell migration a role more important
than to provide an aqueous channel for cell-to-cell communication.
In the rat embryonic cerebral cortex for example, such interactionswould enable leading process stabilization along radial ﬁbers as well
as the subsequent translocation of the soma [166].
6.3. Immune response
The molecular mechanism(s) governing inﬂammasome (the mul-
tiprotein complex involved in innate immunity) signaling still re-
mains poorly deﬁned; the Panx1/P2X7 complex has been suggested
to represent a crucial component of the inﬂammasome (see for exam-
ple [89,225]). Neutrophil activation was abolished and innate host re-
sponses to bacterial infection were impaired by inhibiting or silencing
panx1 hemichannels or P2Y2 receptors [226]. T-cell receptor/CD28
stimulation was seen to rapidly (within 5 min) cause translocation
of Panx1 to the immune synapse [227].
6.4. Skin, hearing and vision
A large variety of connexins is present in the epidermis (8 Cxs are
for example expressed in mouse epidermis with overlapping expres-
sion patterns in the different epidermal layers; [228]). Some of the
mutations in Cx26, Cx30 and Cx31 are linked not only with deafness,
but also with skin disorders; Rouan et al. [229] observed in carriers of
the Cx26 mutation ΔE42 (where the amino acid residue 42 is elimi-
nated), focal Cx26/Cx43 co-localizations at gap junctional plaques in
affected skin tissues. When expressed in oocytes, Cx26 mutants im-
paired GJIC, possibly by hindering Cx43 channel formation or, alterna-
tively, by their gained ability to interact with Cx43, locking up Cx43
into nonfunctional channels. Changing the amino acids within the
ﬁrst extracellular domain might, as suggested by Thomas et al.
[230], alter the compatibility for oligomerization partners. More
than 97% of mice in which the Cx43-CT had been truncated
(Cx43K258stop) die shortly after birth due to a defect of the epider-
mal barrier [228,231]. The authors suggested that the deletion of
the last 125 aa residues of the CT not only impairs channel closure
by intramolecular protein–protein interaction but might also prevent
the interactions of Cx43 with partner proteins.
Gap junctions are important in maintaining lens transparency and
metabolic homeostasis, and the appropriate heteromeric assembly of
Cx46 and Cx50 appears crucial for the clarity and growth of the lens
(see [232]). These proteins have mutually exclusive developmental
patterns and function as well as differential protein–protein interac-
tions, Cx46 segregating in lipids rafts and interacting with caveolin-
1 within the lipid rafts whereas Cx50 was excluded from lipid rafts
and did not show any interaction with caveolin-1 [115]. A TPA-
induced activation of PKCγ was found to decrease the density of
Cx50 assembled with Cx46 in gap junction plaques [104]. According
to Yu et al. [82] direct interaction of AQP0 with the intracellular
loop domain of Cx45.6 would not affect gap junction-mediated inter-
cellular communication.
6.5. Cardiovascular health and disease
GJ channels play essential roles in the normal function of the car-
diovascular system, mediating the spread of the electrical impulse
that triggers synchronized contraction of the cardiac chambers and
contributing to the coordination of activities between cells of the ar-
terial wall. In mammalian hearts, cells most prominently express
junctional channels built of Cx40, Cx43 and Cx45, each of them hav-
ing a characteristic developmental and regional expression pattern
in the heart (see [110]). In the major arteries, endothelial gap junc-
tions may simultaneously express Cx37, -40 and -43 whereas under-
lying medial smooth muscle predominantly expresses Cx43, with
Cx45 additionally expressed at restricted sites (see [233]). Hetero-
meric connexin channels form between all the heart Cxs, although
there is still little functional data concerning their impact on cardiac
conduction. Heterotypic channels display asymmetric voltage
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impulse propagation (in the AV nodal region, from atria to ventricles,
for example).
In the vascular cell co culture model developed by Isakson and
Duling [234], Cx37 for example was speciﬁcally excluded from
myoendothelial junctions between endothelial cells and smoothmus-
cle cells but was present into junctions interconnecting either two ad-
jacent endothelial cells or two adjacent smooth muscle cells. This
suggests that Cx hetero-oligomerization, based on the spatial organi-
zation of Cx distribution within the cells, allows to engender different
classes of cell-to-cell interconnections, inﬂuencing intercellular sig-
naling pathways.
In the heart, adherens junctions appear to nucleate GJs, and dis-
ruption of mechanical coupling has been suggested to lead, via the
loss of GJIC, to different cardiomyopathies [235,236]. Mutations in
genes encoding different desmosomal proteins (plakoglobin, desmo-
plakin, plakophilin 2 and desmoglein 2) have for example been iden-
tiﬁed in patients with arrhythmogenic right ventricular dysplasia/
cardiomyopathy (see [237] for references). The gap junction remo-
deling observed in different cardiac pathologies has been suggested
to result from alterations in Cx43/ZO-1 interaction [182,238]. ZO-1
forms with N-cadherin a multiprotein complex which, according to
Palatinus et al. [239], would be a key determinant of stable localiza-
tion of both adherens junctions and gap junctions at the ID. This is
consistent with previous observations that cardiac-speciﬁc deletion
of N-cadherin led to alteration in Cx40 and Cx43, disassembly of the
ID structure and conduction slowing and arrhythmogenesis in adult
mice [240,241]. Ferreira-Cornwell et al. [242] examined the effect of
expression of either E-cadherin or N-cadherin in the heart of trans-
genic mice, and observed that misexpression of E-cadherin led to car-
diomyopathy, with earlier onset and increased mortality compared
with N-cadherin mice, with a dramatic decrease in Cx43. Silencing
of plakophilin 2 expression resulted in cardiomyocytes of new-born
rat in a drastic loss of Cx43 gap junction plaques, a signiﬁcant redistri-
bution of Cx43 and a decrease in intercellular dye coupling [243].
Smyth et al. [160] observed that microtubule plus-end tracking
protein EB1 was displaced in ischemic human hearts, stressed
mouse hearts, and isolated cells subjected to oxidative stress and
shown that microtubule-dependent forward trafﬁcking of Cx43 to
the plasma membrane was a signiﬁcant contributor to losses in
cell–cell coupling during heart disease.
According to Vessey et al. [212], brief periods of ischemia/reperfu-
sion would induce the formation of Panx1/P2X7 channels, allowing
the release of multiple cardioprotectants that mediate the protection
of ischemic preconditioning and ischemic post-conditioning.
6.6. Nervous systems (CNS and PNS)
Cell interconnections in the central nervous system involve both
chemical synapses and electrical synapses (gap junctions). In contrast
with the regulation of chemical transmission, known to involve direct
interactions of ligand-gated ion channels with different scaffold pro-
teins, playing essential roles by facilitating channel insertion, anchor-
ing, or removal from the plasmamembrane (see for references [244]),
little is still known concerning the importance of protein interactions
in regulating electrical synapses.
At least 11 connexin subtypes coexist in the CNS (see for example
[245]) and form channels which exhibit a great complexity in their
composition and properties. In the mouse CNS, astrocyte Cx26 associ-
ates mainly with oligodendrocyte Cx32, whereas astrocyte Cx43 and
Cx30 associate with oligodendrocyte Cx47 [246]. The signiﬁcance of
this diversity as well as the temporal expression patterns for the dif-
ferent connexins in neurons, astrocytes, oligodendrocytes, Schwann
cells and glia have not yet been determined.
Drebrin, whose level is greatly decreased in brains of Alzheimer
patients (see [50]), appears required for maintaining Cx43-madejunctional channels in their functional state at the plasma membrane
[50]. Flores et al. [244] observed that Cx35CT15/PDZ-1 interaction
was of lower afﬁnity and exhibited faster dissociation kinetics than
Cx43CT20/PDZ-2 interaction and suggested that these characteristics
could allow faster kinetics and more dynamic interactions between
these two proteins, consistent with an involvement in synaptic
plasticity.
Electrical synapses were for a long time considered to be less mod-
iﬁable than chemical synapses, where activity-dependent plasticity
has been ascribed to CaMKII activity, particularly in glutamatergic
synapse, but this key enzyme now appears to undergo activity-
dependent synaptic potentiation as well (see [108]). Cx36, the most
common Cx at electrical synapses in mammals, was proposed to in-
teract with and to be phosphorylated by CaMKII in a way similar to
CaMKII phosphorylation of glutamate receptors [108].
7. Conclusions and perspectives
It progressively emerged in recent years that gap junction proteins
do not operate as free-ﬂoating entities in the plasma membrane, but
rather interact with a range of partner proteins that link them to
the cytoskeleton and to signal transduction pathways (forming a
macromolecular structure tentatively represented in Fig. 2). Such as-
sociations are likely to be important for correct targeting of channels
to speciﬁc subcellular sites, for immobilization and clustering of the
cell-to-cell channels, for the ability of channels to funnel ions and
small molecules, and for modulation of the channel functions by ki-
nases, phosphatases, and other regulatory proteins. Thus the elucida-
tion of interactions with partner proteins promises to reveal a great
deal about the function, regulation, and cell biology of gap junctional
proteins. The latter may also, through their protein partners, be in-
volved in cell functions very different from their tunnel-forming func-
tions. Such structures, with six C-tails exposed per hemichannel (and
thousands of C-tails per gap junction plaque) bind diverse signaling
and structural proteins and thus form a frame crucial for develop-
ment and tissue maintenance. The sequestration of transcription fac-
tors (e.g. ZONAB, Jun, Fos, etc.), via their interaction with ZOs, at the
plasma membrane in the close vicinity of junctional structures sug-
gests that gap junctional proteins might have additional functions in
the regulation of gene expressions. Such interactions of gap junctional
proteins with protein partners appear to have been conserved
through evolution, very likely reﬂecting their functional importance.
It is however essential to keep in mind that the identiﬁcation of
partners of gap junctional proteins, as of partners of other membrane
proteins (e.g.membrane receptors, transporters, and ion channels), pro-
teinwhich span themembranemultiple times and fold into special struc-
tures involving non-linear peptide loops, require rigorous biochemical
evidence via multiple approaches. Co-localization observations in immu-
noﬂuorescence microscopy need additional approaches (including for
example in vitro binding assays, co-immunoprecipitation) to substantiate
their interactions with the identiﬁed proteins. On the other hand,
the screening of protein–protein interaction frequently results in
identiﬁcation of interactions which, although reproducible and
speciﬁc, are not easily assessed. This is mainly due to the fact that
proteins are misexpressed in a compartment from which they are
typically excluded and therefore may be exposed to a repertoire of
proteins that are not accessible in their natural environments. In ad-
dition, the fusion of a protein or a protein fragment to an effector
protein (e.g. in two-hybrid or protein recruitment approaches) may
result in misfolding of the protein and exposure of protein surfaces
that are typically not accessible for association with other proteins.
It is why the present survey was, for interactions between gap junc-
tion proteins, limited to observations made in systems where they
were endogenously expressed.
In conclusion, gap junctional proteins increasingly appear as
members of large signaling complexes including membrane
Fig. 2. Round about gap junctions. Artistic view of some of the cellular proteins found associated with Cx43- or Pannexins-made channels or in their close surrounding.
1860 J.-C. Hervé et al. / Biochimica et Biophysica Acta 1818 (2012) 1844–1865receptors, proteins of other cell junctions, enzymes (PKs, PPs, …),
scaffolding proteins (e.g. ZOs), transcription factors and cytoskeleton.
The importance of protein–protein interactions in the regulation of
the trafﬁcking, assembly and disassembly of junctional proteins, as
well as the dynamic modulation of the opening state of junctional
channels are progressively gaining support. Communication through
such channels is sensitive to a variety of stimuli, including changesin the level of intracellular Ca2+, pH, transjunctional applied voltage
and phosphorylation/dephosphorylation processes. The ﬁnding that,
in addition to their well-described function of transmembrane con-
duits, these structures participate in intracellular signaling pathways
could provide an explanation for the number of genes that encode
channel subunits. With heteromer formation, alternative splicing of
mRNA and post-translational modiﬁcations, the potential number of
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erable. The speciﬁc linkage of different channel subfamilies to differ-
ent signaling pathways could not only provide a raison d' être for a
large number of channels that apparently have not very different
properties, but might also help to explain the high degree of conser-
vation in the sequences of different subfamilies of junctional channels
throughout evolution. However, the identiﬁcation of the cytoskeletal
and signaling proteins that interact with gap junction proteins is only
a ﬁrst step in a long endeavor. The major challenges of the future are
to quantify the stoichiometry of these protein–protein interactions, to
picture their geometry by microscopic and structural biological ap-
proaches, to make out the hierarchy of organization, to reveal the dy-
namic regulation of gap junctional complexes and, perhaps most
importantly, to understand the functional signiﬁcance of these pro-
tein interactions in intercellular signalization in physiological condi-
tions and associated with diseases.References
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